Expression of hnRNP K in lung adenocarcinoma cells

Journal of Sichuan University (Medical Science)

Volumn 39, Issue 5, 2008, Pages 823-826

  Tang, Feng Ming ^a   Li, Wei Min ^a   Chen, Yan ^a   Wang, Dong Mei ^a   Han, Juan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Heterogeneous nuclear ribonucleoprotein K; Lung adencarcinoma; siRNA

Indexed keywords

EID: 53349165262     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Carpenter B, Mackay C, Alnabulsi A, et al. The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochim Biophys Acta, 2006; 1765(2): 85-100.
2. Bomsztyk K, Denisenko O, Ostrowski J. One protein multiple processes. Bioessays, 2004; 26(6): 629-638.
3. Pino I, Pio R, Toledo G, et al. Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP)family in lung cancer. Lung Cancer, 2003; 41(2): 131-143.
4. Chinese source
5. Michelotti EF, Michelotti GA, Aronsohn AI, et al. Heterogeneous nuclear ribonucleoprotein K is a transcription factor. Mol Cell Biol, 1996; 16(5): 2350-2360.
6. Mandai M, Vadlamudi R, Nguyen D, et al. Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function. J Biol Chem, 2001; 276(13): 9699-9704.
7. Yano M, Okano HJ, Okano H. Involvement of Hu and heterogeneous nuclear ribonucleoprotein K in neuronal differentiation through p21 mRNA post-transcriptional regulation. J Biol Chem, 2005; 280(13):12690-12699.
8. Agami R. RNAi and related mechanisms and their potential use for therapy. Curr Opin Chem Biol, 2002; 6(6): 829-834.
9. Moumen A, Masterson P, Connor MJ,et al. hnRNP K, an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.Cell, 2005; 123(6): 1065-1078.
10. Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene, 2005; 24(17): 2899-2908.